This is the authors' abstract. We don't add key points for this paper.
Diabetes mellitus is a significant global public health challenge, with a rising prevalence and associated morbidity and mortality. Cell therapy has evolved over time and holds great potential in diabetes treatment. In the present review, we discussed the recent progresses in cell-based therapies for diabetes that provides an overview of islet and stem cell transplantation technologies used in clinical settings, highlighting their strengths and limitations. We also discussed immunomodulatory strategies employed in cell therapies. Therefore, this review highlights key progresses that pave the way to design transformative treatments to improve the life quality among diabetic patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Raoufinia et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: